These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1166023)

  • 1. Central effects of certain drugs and allergic encephalomyelitis in the circumstances of increased or decreased histamine in CNS.
    Stern P
    Pol J Pharmacol Pharm; 1975; 27(4):445-50. PubMed ID: 1166023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of specific brain phospholipid on the rat's allergic encephalomyelitis.
    Stern P
    Arzneimittelforschung; 1975 May; 25(5):753-5. PubMed ID: 52363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of in-situ Ia antigen expression in the pathogenesis of autoimmune central nervous system disease.
    Uitdehaag BM; de Groot CJ; Kreike A; van der Meide PH; Polman CH; Dijkstra CD
    J Autoimmun; 1993 Jun; 6(3):323-35. PubMed ID: 8397714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine in the rat brain: effect of acute and chronic treatment with tricyclic antidepressants and H1-antihistaminics.
    Nowak JZ; Zawilska J
    Pol J Pharmacol Pharm; 1985; 37(2):147-62. PubMed ID: 2413428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of histamine in motion sickness in Suncus murinus.
    Kaji T; Saito H; Ueno S; Yasuhara T; Nakajima T; Matsuki N
    Aviat Space Environ Med; 1991 Nov; 62(11):1054-8. PubMed ID: 1741719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
    Matsumoto Y; Hara N; Tanaka R; Fujiwara M
    J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors.
    Zawilska J; Nowak JZ
    Pol J Pharmacol Pharm; 1985; 37(6):821-30. PubMed ID: 3832018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergocryptine protects from acute experimental allergic encephalomyelitis in the rat.
    Canonico PL; Sortino MA; Favit A; Aleppo G; Scapagnini U
    Funct Neurol; 1993; 8(3):183-8. PubMed ID: 8406136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system.
    Garcion E; Sindji L; Nataf S; Brachet P; Darcy F; Montero-Menei CN
    Acta Neuropathol; 2003 May; 105(5):438-48. PubMed ID: 12677443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
    Genoud S; Maricic I; Kumar V; Gage FH
    J Neuroimmunol; 2005 Nov; 168(1-2):40-5. PubMed ID: 16120466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptively transferred experimental allergic encephalomyelitis in chimeric rats: identification of transferred cells in the lesions of the central nervous system.
    Matsumoto Y; Fujiwara M
    Immunology; 1988 Sep; 65(1):23-9. PubMed ID: 3053424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system hemorrhages induced by heparin in rats with allergic encephalomyelitis.
    Levine S; Wenk EJ
    Thromb Diath Haemorrh; 1966 Jul; 16(1):296-301. PubMed ID: 5989047
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.
    Raijmakers R; Vogelzangs J; Raats J; Panzenbeck M; Corby M; Jiang H; Thibodeau M; Haynes N; van Venrooij WJ; Pruijn GJ; Werneburg B
    J Comp Neurol; 2006 Sep; 498(2):217-26. PubMed ID: 16856138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
    Dimitrijević M; Rauski A; Radojević K; Kosec D; Stanojević S; Pilipović I; Leposavić G
    Eur J Pharmacol; 2007 Dec; 577(1-3):170-82. PubMed ID: 17854797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis.
    Chakrabarty A; Danley MM; LeVine SM
    J Neurosci Res; 2004 Jun; 76(6):822-33. PubMed ID: 15160394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological monitoring of experimental allergic neuritis and experimental allergic encephalomyelitis.
    Kraft GH; Slimp JC
    Prog Clin Biol Res; 1984; 146():449-53. PubMed ID: 6326161
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of tissue histamine formation by decaborane.
    Medina MA; Landez JH; Foster LL
    J Pharmacol Exp Ther; 1969 Sep; 169(1):132-7. PubMed ID: 5804607
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GABA-related hypothesis on the mechanism of action of the antimotion sickness drugs.
    Giurgea CE; Moeyersoons FE; Evraerd AC
    Arch Int Pharmacodyn Ther; 1967 Mar; 166(1):238-51. PubMed ID: 4382323
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
    Fissolo N; Kraus M; Reich M; Ayturan M; Overkleeft H; Driessen C; Weissert R
    Eur J Immunol; 2008 Sep; 38(9):2401-11. PubMed ID: 18792018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.